|Stock not rated.|
Last 5 Yrs
Last 3 Yrs
|Payout Amount||Calendar Year||Annual Growth|
|Payout Amount||Declared Date||Ex-Dividend Date||Record Date||Pay Date ▼||Qualified Dividend?||Payout Type||Frequency|
Learn more about Questcor Pharmaceuticals, Inc. on:
Questcor Pharmaceuticals, Inc. (QCOR) manufactures prescription drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications. It primarily offers H.P. Acthar Gel for the treatment of the above mentioned diseases, as well as rheumatology-related conditions. In addition, QCOR offers Doral for the treatment of insomnia. The company sells its Acthar primarily to specialty pharmacies, and Doral to pharmaceutical wholesalers. Questcor Pharmaceuticals, Inc. was founded in 1990 and is headquartered in Anaheim, California. Most of Questcor Pharmaceuticals’ profits are derived from Acthar, and new and existing competitors to Acthar may reduce or eliminate Questcor’s commercial opportunity. Questcor Pharmaceuticals has been paying dividends since 2012 and has increased them consecutively annually since then. Questcor Pharmaceuticals pays its dividends quarterly.